Krishnan Nandabalan

BTAI

Krishnan Nandabalan serves as Director at BioXcel Therapeutics, Inc. (BTAI). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$3.26M

Net Position

Net Seller

$3.26M

Companies Traded

BTAI

Active Period

Nov 2022 – Apr 2023

3 total trades

Most Recent

Sell BTAI

Apr 6, 2023 · $1.04M

Krishnan Nandabalan's Insider Trading at BioXcel Therapeutics, Inc. (BTAI)

Buys

0 · $0.00

Sells

3 · $3.26M

Total Shares Bought

Total Shares Sold

180,000

BTAI Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Apr 6, 2023	Sell	60,000	$17.32	$1.04M
Jan 4, 2023	Sell	60,000	$22.01	$1.32M
Nov 10, 2022	Sell	60,000	$15.00	$900.0K

Related Insiders

Vimal Mehta

director, officer: CEO and President

BTAISell · May 22, 2026

Javier Rodriguez

officer: See Remarks

BTAISell · May 22, 2026

Richard I Steinhart

officer: Chief Financial Officer

BTAISell · May 22, 2026

Frank Yocca

officer: Chief Scientific Officer

BTAISell · May 22, 2026

Explore More Insider Trading Data

BTAI Insider Trading Activity

View all insider trades at BioXcel Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity